Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
88
天
Retrospective (Q)SAR analysis of genotoxicity data from European pharmaceutical scientific advice and authorization procedures and performance improvements using structural alert and chemical subspace analyses, reliability filtering, and expert review
作者
Ajouan Mazoudji; Daniela Digles; Manfred Schuster; Alan Sanh; Fabien Lavergne; Martin Paparella; Gerhard F. Ecker; Martin Walter展开收起
作者单位
Austrian Agency for Health and Food Safety GmbH, Austrian Medicines & Medical Devices Agency (AGES-MEA), Traisengasse 5, Vienna, 1200, Austria; University of Vienna, Department of Pharmaceutical Sciences, Josef-Holaubek-Platz 2, Vienna, 1090, Austria; French National Agency for Medicines and Health Products Safety (ANSM), 43/147, boulevard Anatole France, 93285, Saint-Denis Cedex, France; Medical University of Innsbruck, Institute of Medical Biochemistry, Innrain 80-82, Innsbruck, A-6020, Austria展开收起
119
天
Mutagenicity studies on migrants from food-contact silicone products based on Ames test and chemical analysis
作者
Peixue Guo; Zhaoxi Liu; Jin Rong; Xueting Feng; Xiaojie Fan; Di Feng展开收起
作者单位
Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, China展开收起
64
天
Establishment of expanded botanical thresholds of toxicological concern: Enrichment of botanical PoD databases and new thresholds
作者
Gyeyoung Choi; Eunsu Kim; Jieun Lee; Seo Young Shin; YoungMi Kim; Boyeon Kim; Yeyoung Kim; Haneul Kim; Seonmin Park; Eunseo Seo; Seungjin Bae; Kyung-Min Lim展开收起
作者单位
College of Pharmacy, Ewha Womans University, Seoul, South Korea; Graduate Program in Regulatory Science Convergence, Ewha Womans University, Seoul, South Korea展开收起
5
天
New approach methodologies in pharmaceutical development: Survey insights on adoption, infrastructure, and the path to broader implementation
作者
Jessica C. Graham; Brandy Morenko; Damodaran Annamalai; Fatima Arjmand; Monika Burns; Danielle Elbirt; Brianna N. Gaskill; Moran Grossman; Dawn S.Y. Lin; Kathy Orsted; Rosemary Santos; Alanna Sedgwick; Margit Spatzenegger展开收起
作者单位
Eli Lilly and Company, Indianapolis, IN, USA; Pfizer Inc., Groton, CT, USA; Biogen Inc, Cambridge, MA, USA; Gilead Sciences Inc., Foster City, CA, USA; Novartis Biomedical Research, Cambridge, MA, USA; MilliporeSigma, Burlington, MA, USA; Teva Pharmaceutical Industries Ltd., Netanya, Israel; Merck & Co., Inc., Rahway, NJ, USA; Vividion Therapeutics, San Diego, CA, USA; CSL Behring GmbH, Vienna, Austria展开收起
69
天
Suitability of the ICH S1B(R1) weight-of-evidence framework to evaluate glucagon-like protein-1 receptor agonist (GLP-1RA) carcinogenicity risk
作者
Katherine A. Roach; Manoochehr Khazaee; Isaac Mohar; Denali Boon; Brigitte Cronin; Alex G. Gauthier展开收起
作者单位
Gradient, 103 East Water Street, Charlottesville, VA, 22902, USA; Gradient, 801 5th Ave., Suite 2200, Seattle, WA, 98104, USA; Gradient, One Beacon Street, 17th Floor, Boston, MA, 02108, USA; Novartis Pharma AG, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA展开收起
102
天
Multi-pathway human exposure to NORM from facial foundation powders available on the Turkish market: Assessing lifetime cancer risks for adult users
作者
Şeref Turhan; Celalettin Enes Demirci; Aslı Kurnaz展开收起
作者单位
Department of Physics, Faculty of Science, Kastamonu University, Kastamonu, 37150, Turkey; Department of Physics, Graduate Education Institute, Kastamonu University, Kastamonu, 37150, Turkey展开收起
FAQ
REGULATORY TOXICOLOGY AND PHARMACOLOGY审稿要多久?
截至2026-11-19,CrushSCI 收录了 REGULATORY TOXICOLOGY AND PHARMACOLOGY 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 5 天(New approach methodologies in pharmaceutical development: Survey insights on adoption, infrastructure, and the path to broader implementation,2026-09-24 收稿,2026-09-29 录用),最慢一篇用了 205 天;平均 118.4 天,中位数 110.5 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
